Circulating microRNAs are beneficial biomarkers because of their stability and dysregulation in diseases. Here we sought to determine the role of miR-939, a miRNA downregulated in patients with complex regional pain syndrome (CRPS). Hsa-miR-939 is predicted to target several proinflammatory genes, including IL-6, VEGFA, TNF alpha, NF kappa B2, and nitric oxide synthase 2 (NOS2A). Binding of miR-939 to the 3' untranslated region of these genes was confirmed by reporter assay. Overexpression of miR-939 in vitro resulted in reduction of IL-6, NOS2A and NF kappa B2 mRNAs, IL-6, VEGFA, and NOS2 proteins and NF kappa B activation. We observed a significant decrease in the NOS substrate l-arginine in plasma from CRPS patients, suggesting reduced miR-939 levels may contribute to an increase in endogenous NOS2A levels and NO, and thereby to pain and inflammation. Pathway analysis showed that miR-939 represents a critical regulatory node in a network of inflammatory mediators. Collectively, our data suggest that miR-939 may regulate multiple proinflammatory genes and that downregulation of miR-939 in CRPS patients may increase expression of these genes, resulting in amplification of the inflammatory pain signal transduction cascade. Circulating miRNAs may function as crucial signaling nodes, and small changes in miRNA levels may influence target gene expression and thus disease.
Regulation of proinflammatory genes by the circulating microRNA hsa-miR-939
Creators
Marguerite K. McDonald - Drexel University
Sujay Ramanathan - Drexel University
Andrew Touati - Drexel University
Yiqian Zhou - Drexel University
Rushi U. Thanawala - Drexel University
Guillermo M. Alexander - Drexel University
Ahmet Sacan - Drexel University
Seena K. Ajit - Drexel University
Publication Details
Scientific reports, v 6(1), pp 30976-30976
Publisher
Springer Nature
Number of pages
11
Grant note
NINDS 1R21NS082991-01 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
Rita Allen Foundation
R21NS082991 / NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
Resource Type
Journal article
Language
English
Academic Unit
Pharmacology and Physiology; School of Biomedical Engineering, Science, and Health Systems; [Retired Faculty]
Web of Science ID
WOS:000381457900001
Scopus ID
2-s2.0-84981210537
Other Identifier
991019168348704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: